tiprankstipranks
BioAdaptives (BDPT)
OTHER OTC:BDPT
US Market
Holding BDPT?
Track your performance easily

BioAdaptives (BDPT) Income Statement

18 Followers

BioAdaptives Income Statement

Last quarter (Q ), BioAdaptives's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, BioAdaptives's net income was $-37.65K. See BioAdaptives’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 15.01K$ 28.57K$ 17.18K$ 19.78K$ 16.33K$ 9.93K
Cost of Revenue
$ 9.49K$ 17.75K$ 10.05K$ 9.67K$ 10.23K$ -5.05K
Gross Profit
$ 4.66K$ 10.82K$ 7.13K$ 10.11K$ 6.09K$ 4.88K
Operating Expense
$ 326.22K$ 239.74K$ 429.03K$ 646.19K$ 260.42K$ -239.29K
Operating Income
$ -320.70K$ -228.92K$ -411.85K$ -626.41K$ -567.96K$ -238.93K
Net Non Operating Interest Income Expense
$ -134.53K$ -162.89K$ -299.17K$ -272.39K$ -230.33K$ -199.32K
Other Income Expense
$ 216.06K$ -320.65K$ 184.55K$ 39.47K$ 362.59K$ -3.21K
Pretax Income
$ -589.94K$ -712.47K$ -895.57K$ -947.95K$ -2.01M$ -238.93K
Tax Provision
$ 306.71K-----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -671.29K$ -712.47K$ -895.57K$ -1.05M$ -847.24K$ -633.04K
Basic EPS
----$ -0.04-
Diluted EPS
----$ -0.04$ -0.01
Basic Average Shares
$ 1.34B-$ 106.01M-$ 20.39M$ 18.65M
Diluted Average Shares
$ 1.34B-$ 106.01M-$ 20.39M$ 7.92M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 335.71K$ 257.49K$ 439.08K$ 655.86K$ 270.65K$ -244.34K
Net Income From Continuing And Discontinued Operation
$ -671.29K$ -712.47K$ -895.57K$ -1.05M$ -847.24K$ -633.04K
Normalized Income
$ -441.56K$ -3.35M----
Interest Expense
------
EBIT
$ -536.76K$ -549.58K$ -606.45K$ -777.55K$ -616.92K$ -39.61K
EBITDA
$ -439.39K$ -521.40K$ -544.30K$ -643.76K$ -616.92K$ 118.47K
Currency in USD

BioAdaptives Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis